Profile
Helping patients across multiple diseasesRevenue split by therapeutic areas1
Servicing a diversified customer baseRevenue split by customer type1
Solutions along the value chainRevenue split by business segment and number of active custom projects by stage of development1
1 Approximate splits as per 31 December 2021.
Business model Providing expert knowledge for peptide-based API's across the entire value chain
API – Active Pharmaceutical Ingredient; CMC – Chemistry, Manufacuring & Controls; GMP – Good Manufacturing Practice; ICH – International Council for Harmonization; LCM – Life Cycle Management; NDA – New Drug Application; PPQ – Process Performance Qualification.
Integrated strategyStriving to be the preferred long-term partner for customers
Footprint and customer proximityExperienced team1 and GMP-certified manufacturing network
1 Data based on headcount as of 31 December 2021.
Striving for profitable growthBuilding on favorable market trends
1 For a reconcilliation to the nearest IFRS line item, please refer to the section “Definitions and reconciliations” of this report.